Oxytocin responses to insulin and glucose: Impact of lactation and obesity
催产素对胰岛素和葡萄糖的反应:哺乳和肥胖的影响
基本信息
- 批准号:8243875
- 负责人:
- 金额:$ 22.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-03-01 至 2014-02-28
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAbbreviationsAddressAdultAlzheimer&aposs DiseaseAnorexiaAppetite DepressantsAppetite RegulationBlood CirculationBrainCalciumCalcium ChannelCell NucleusCell physiologyDesire for foodDiabetes MellitusDiestrusDietDiseaseEatingEpidemicFemaleFigs - dietaryGLUT-3 proteinGLUT4 geneGastric BypassGlucokinaseGlucoseGlucose TransporterGoalsHealthHormonalHormonesHumanHypothalamic structureImmunohistochemistryIndividualInsulinInsulin ReceptorInsulin ResistanceInterventionLaboratoriesLactationLigandsLobeMediatingMinorMonitorMusNeuronsNutrientObesityOxytocinOxytocin ReceptorPeripheralPlayPotassium ChannelProductionRattusResistanceRiskRoleSatiationSignal TransductionSourceStimulusStructure of beta Cell of isletSystemTestingVasopressinsWeight Gainexperienceextracellularfeedingglucokinase receptorglucose monitorglucose sensorglucose uptakehormone regulationhypertensive heart diseaseindexinginsulin sensitivitymRNA Expressionmagnocellularmalemeetingsnovelparaventricular nucleusparvocellularpreventreceptorrelating to nervous systemresponsesupraoptic nucleustreatment strategyvoltage
项目摘要
DESCRIPTION (provided by applicant): Glucokinase and insulin receptors (InsR) are abundant in the hypothalamic supraoptic nucleus (SON). The goal of this application is to develop background information to determine if the oxytocin (OT) neurons in SON utilize these molecules to monitor body nutrient status. The presence of glucokinase in other neurons and cells that function as glucose sensors (e.g. pancreatic beta cells and neurons in recognized appetite regulating centers) suggests that glucose-sensitivity may allow the OT neurons to monitor extracellular glucose and thereby respond appropriately to induce anorexia after a meal. Insulin is also recognized as a satiety-inducing signal. Thus, the presence of InsR in OT neurons may provide a second mechanism for the OT neurons to monitor changes in body nutrient status. Since OT is a recognized anorexic agent (e.g. suppresses food intake), alterations in the control of OT secretion may contribute to obesity and/or provide alternate treatment strategies to prevent or reverse obesity. The specific aims of the proposal are: 1. To test the hypothesis that magnocellular OT neurons function as glucose sensors and monitor hormonal indices of body nutrient stores. 2. To test the hypothesis that lactation alters the effect of glucose and insulin on OT release. 3. To test the hypothesis that the role of glucokinase and InsR in SON is altered by diet- induced obesity. Explants of the hypothalamo-neurohypophyseal system (HNS) will be used to determine the effect of glucose and insulin on OT and VP release and to determine if intracellular calcium ([Ca2+]i) signaling is altered in OT and VP SON neurons by glucose and/or insulin. Both hypothalamic and neural lobe hormone release will be monitored, because OT acts centrally to induce anorexia, and dendritic and/or en passant axonal OT release is thought to be the source of ligand for OT receptors (OTR) in 'satiety neurons' of the ventromedial nucleus. Since lactation is associated with both stimulation of OT release and increased food intake, it is possible that the impact of glucose and insulin on OT release is altered during lactation and that similar changes contribute to the difficulty that obese individuals experience in reducing food intake.
PUBLIC HEALTH RELEVANCE: Obesity is a significant health concern, because currently more than 30% of adults in the USA are obese and obesity increases the risk for other major diseases including hypertension, heart disease, diabetes, and Alzheimer's disease. In spite of intense efforts, we still lack interventions for preventing or reversing obesity that are helpful to the majority of people. This proposal will evaluate the effect of appetite regulating signals on oxytocin release, an agent know to suppress food intake.
描述(由申请人提供):下丘脑视上核(SON)中富含葡萄糖激酶和胰岛素受体(InsR)。该应用的目标是开发背景信息,以确定 SON 中的催产素 (OT) 神经元是否利用这些分子来监测身体营养状态。其他神经元和充当葡萄糖传感器的细胞(例如胰腺β细胞和公认的食欲调节中心的神经元)中存在葡萄糖激酶,这表明葡萄糖敏感性可能使OT神经元能够监测细胞外葡萄糖,从而在进食后做出适当反应以诱发厌食症。一顿饭。胰岛素也被认为是一种引起饱腹感的信号。因此,OT神经元中InsR的存在可能为OT神经元监测身体营养状态变化提供第二种机制。由于 OT 是公认的厌食剂(例如抑制食物摄入),因此 OT 分泌控制的改变可能会导致肥胖和/或提供替代治疗策略来预防或逆转肥胖。该提案的具体目标是: 1. 检验大细胞 OT 神经元充当葡萄糖传感器并监测身体营养储存的激素指数的假设。 2. 检验以下假设:哺乳会改变葡萄糖和胰岛素对 OT 释放的影响。 3. 检验饮食诱导的肥胖会改变葡萄糖激酶和 InsR 在 SON 中的作用的假设。下丘脑-神经垂体系统 (HNS) 的外植体将用于确定葡萄糖和胰岛素对 OT 和 VP 释放的影响,并确定葡萄糖和 VP SON 神经元中的细胞内钙 ([Ca2+]i) 信号是否改变。 /或胰岛素。下丘脑和神经叶激素的释放都将受到监测,因为 OT 的作用集中于诱导厌食,而树突和/或经过的轴突 OT 释放被认为是大脑“饱腹感神经元”中 OT 受体 (OTR) 的配体来源。腹内侧核。由于哺乳期与刺激 OT 释放和增加食物摄入有关,因此葡萄糖和胰岛素对 OT 释放的影响可能在哺乳期间发生改变,并且类似的变化导致肥胖个体在减少食物摄入方面遇到困难。
公共卫生相关性:肥胖是一个重大的健康问题,因为目前美国有超过 30% 的成年人肥胖,并且肥胖会增加患其他主要疾病的风险,包括高血压、心脏病、糖尿病和阿尔茨海默病。尽管付出了巨大的努力,我们仍然缺乏对大多数人有帮助的预防或逆转肥胖的干预措施。该提案将评估食欲调节信号对催产素释放的影响,催产素是一种抑制食物摄入的药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CELIA D SLADEK其他文献
CELIA D SLADEK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CELIA D SLADEK', 18)}}的其他基金
Oxytocin responses to insulin and glucose: Impact of lactation and obesity
催产素对胰岛素和葡萄糖的反应:哺乳和肥胖的影响
- 批准号:
8431741 - 财政年份:2012
- 资助金额:
$ 22.69万 - 项目类别:
Neurokinin 3 Receptor: Nuclear Localization in Supraoptic Neurons
神经激肽 3 受体:视上神经元的核定位
- 批准号:
7471320 - 财政年份:2008
- 资助金额:
$ 22.69万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6845349 - 财政年份:2002
- 资助金额:
$ 22.69万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
7047737 - 财政年份:2002
- 资助金额:
$ 22.69万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6556138 - 财政年份:2002
- 资助金额:
$ 22.69万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6640699 - 财政年份:2002
- 资助金额:
$ 22.69万 - 项目类别:
Neuropeptide Regulation Vasopressin/Oxytocin Secretion
神经肽调节加压素/催产素分泌
- 批准号:
6710592 - 财政年份:2002
- 资助金额:
$ 22.69万 - 项目类别:
PILOT PROJECT--GENE REGULATION IN VASOPRESSIN NEURONS DURING AGING
试点项目——衰老过程中加压素神经元的基因调控
- 批准号:
6098263 - 财政年份:1996
- 资助金额:
$ 22.69万 - 项目类别:
相似海外基金
The Na/K-ATPase receptor function as a novel therapeutic target in myocardial infarction
Na/K-ATP酶受体作为心肌梗死的新型治疗靶点
- 批准号:
9813314 - 财政年份:2019
- 资助金额:
$ 22.69万 - 项目类别:
Dysregulated Metabolic Cell Cycle Checkpoints in Human Cancer
人类癌症中代谢细胞周期检查点失调
- 批准号:
8910668 - 财政年份:2014
- 资助金额:
$ 22.69万 - 项目类别:
Dysregulated Metabolic Cell Cycle Checkpoints in Human Cancer
人类癌症中代谢细胞周期检查点失调
- 批准号:
8773710 - 财政年份:2014
- 资助金额:
$ 22.69万 - 项目类别:
Oxytocin responses to insulin and glucose: Impact of lactation and obesity
催产素对胰岛素和葡萄糖的反应:哺乳和肥胖的影响
- 批准号:
8431741 - 财政年份:2012
- 资助金额:
$ 22.69万 - 项目类别:
Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac Diseases
受体 Na/K-ATP 酶拮抗剂作为肾病/心脏病的新型疗法
- 批准号:
8159937 - 财政年份:2011
- 资助金额:
$ 22.69万 - 项目类别: